Atara Biotherapeutics Stock Price History
| ATRA Stock | USD 10.00 0.29 2.99% |
Below is the normalized historical share price chart for Atara Biotherapeutics extending back to October 16, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Atara Biotherapeutics stands at 10.00, as last reported on the 20th of July, with the highest price reaching 10.99 and the lowest price hitting 9.78 during the day.
If you're considering investing in Atara Stock, it is important to understand the factors that can impact its price. Atara Biotherapeutics appears to be somewhat reliable, given 3 months investment horizon. Atara Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19 % return per unit of standard deviation over the last 3 months. By analyzing Atara Biotherapeutics' technical indicators, you can evaluate if the expected return of 0.88% is justified by implied risk. Please makes use of Atara Biotherapeutics' mean deviation of 3.31, and Risk Adjusted Performance of 0.1956 to double-check if our risk estimates are consistent with your expectations. At present, Atara Biotherapeutics' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 7.9 M, whereas Total Stockholder Equity is projected to grow to (92.4 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 0.73. Atara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of October 2014 | 200 Day MA 8.8826 | 50 Day MA 8.1381 | Beta 0.177 |
Sharpe Ratio = 0.1909
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATRA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.61 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.88 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Atara Biotherapeutics is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atara Biotherapeutics by adding it to a well-diversified portfolio.
Price Book 1.9674 | Enterprise Value Ebitda (0.35) | Price Sales 0.3402 | Shares Float 3.4 M | Wall Street Target Price 16 |
Atara Biotherapeutics Stock Price History Chart
There are several ways to analyze Atara Stock price data. The simplest method is using a basic Atara candlestick price chart, which shows Atara Biotherapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 18, 2025 | 10.0 |
| Lowest Price | May 12, 2025 | 6.47 |
Atara Biotherapeutics July 20, 2025 Stock Price Synopsis
Various analyses of Atara Biotherapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Atara Stock. It can be used to describe the percentage change in the price of Atara Biotherapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Atara Stock.| Atara Biotherapeutics Price Daily Balance Of Power | 0.24 | |
| Atara Biotherapeutics Price Rate Of Daily Change | 1.03 | |
| Atara Biotherapeutics Price Action Indicator | (0.24) |
Atara Biotherapeutics July 20, 2025 Stock Price Analysis
Atara Stock Price History Data
The price series of Atara Biotherapeutics for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 4.16 with a coefficient of variation of 12.73. The prices are distributed with arithmetic mean of 7.86. The median price for the last 90 days is 7.8. The company had 1:25 stock split on 20th of June 2024.| Open | High | Low | Close | Volume | ||
07/20/2025 | 9.80 | 10.99 | 9.78 | 10.00 | ||
07/18/2025 | 9.80 | 10.99 | 9.78 | 10.00 | 112,212 | |
07/17/2025 | 9.30 | 9.80 | 8.53 | 9.71 | 78,662 | |
07/16/2025 | 9.20 | 9.29 | 8.82 | 9.28 | 39,558 | |
| 07/15/2025 | 9.29 | 9.62 | 8.77 | 9.27 | 82,905 | |
| 07/14/2025 | 9.33 | 9.44 | 9.16 | 9.30 | 30,285 | |
07/11/2025 | 9.60 | 9.60 | 9.11 | 9.23 | 23,402 | |
07/10/2025 | 9.25 | 9.60 | 9.25 | 9.48 | 35,112 | |
07/09/2025 | 9.36 | 9.44 | 9.07 | 9.23 | 35,576 | |
07/08/2025 | 8.61 | 9.35 | 8.43 | 9.27 | 41,374 | |
07/07/2025 | 8.30 | 8.68 | 8.21 | 8.58 | 33,794 | |
07/03/2025 | 8.25 | 8.62 | 8.11 | 8.47 | 18,894 | |
07/02/2025 | 7.88 | 8.35 | 7.88 | 8.25 | 31,148 | |
07/01/2025 | 7.60 | 8.02 | 7.54 | 7.80 | 20,120 | |
| 06/30/2025 | 7.93 | 8.07 | 7.60 | 7.72 | 18,849 | |
06/27/2025 | 7.94 | 8.15 | 7.80 | 7.96 | 22,267 | |
06/26/2025 | 8.09 | 8.18 | 7.81 | 7.95 | 27,698 | |
06/25/2025 | 8.25 | 8.25 | 7.76 | 8.02 | 15,429 | |
06/24/2025 | 8.01 | 8.20 | 7.73 | 8.06 | 29,533 | |
06/23/2025 | 7.83 | 8.08 | 7.68 | 7.88 | 16,739 | |
06/20/2025 | 8.05 | 8.05 | 7.51 | 7.94 | 86,859 | |
| 06/18/2025 | 7.92 | 8.28 | 7.79 | 8.02 | 71,466 | |
06/17/2025 | 8.38 | 8.38 | 7.74 | 7.80 | 45,473 | |
06/16/2025 | 9.00 | 9.00 | 8.32 | 8.58 | 39,430 | |
06/13/2025 | 8.57 | 8.86 | 8.50 | 8.82 | 34,168 | |
06/12/2025 | 8.88 | 8.88 | 8.56 | 8.71 | 43,134 | |
06/11/2025 | 9.14 | 9.21 | 8.62 | 8.91 | 55,468 | |
| 06/10/2025 | 9.27 | 9.40 | 8.75 | 9.12 | 48,474 | |
06/09/2025 | 9.34 | 9.68 | 9.00 | 9.26 | 66,437 | |
06/06/2025 | 8.52 | 9.23 | 8.48 | 9.23 | 93,303 | |
06/05/2025 | 8.42 | 8.64 | 8.23 | 8.42 | 38,620 | |
06/04/2025 | 8.48 | 8.55 | 8.21 | 8.33 | 61,936 | |
06/03/2025 | 7.90 | 8.42 | 7.75 | 8.39 | 64,680 | |
06/02/2025 | 7.82 | 8.13 | 7.63 | 8.00 | 93,691 | |
05/30/2025 | 7.71 | 7.88 | 7.44 | 7.80 | 55,473 | |
05/29/2025 | 7.89 | 8.10 | 7.53 | 7.80 | 79,059 | |
05/28/2025 | 7.46 | 7.86 | 7.36 | 7.80 | 46,487 | |
05/27/2025 | 7.20 | 7.64 | 7.20 | 7.49 | 63,503 | |
05/23/2025 | 7.11 | 7.33 | 6.93 | 7.14 | 59,986 | |
05/22/2025 | 6.88 | 7.33 | 6.80 | 7.11 | 81,506 | |
05/21/2025 | 6.82 | 7.32 | 6.82 | 6.90 | 67,446 | |
05/20/2025 | 6.73 | 7.20 | 6.62 | 7.00 | 75,613 | |
05/19/2025 | 6.76 | 7.07 | 6.50 | 6.73 | 132,356 | |
05/16/2025 | 7.50 | 7.50 | 6.76 | 6.84 | 114,071 | |
05/15/2025 | 7.49 | 7.99 | 7.01 | 7.61 | 191,060 | |
05/14/2025 | 6.72 | 6.72 | 6.51 | 6.61 | 30,203 | |
05/13/2025 | 6.50 | 6.94 | 6.45 | 6.68 | 94,181 | |
05/12/2025 | 7.74 | 7.76 | 6.39 | 6.47 | 103,579 | |
05/09/2025 | 7.44 | 7.80 | 7.27 | 7.27 | 26,418 | |
05/08/2025 | 7.24 | 7.62 | 6.90 | 7.42 | 55,246 | |
05/07/2025 | 7.60 | 7.64 | 7.19 | 7.26 | 38,217 | |
05/06/2025 | 8.00 | 8.65 | 7.43 | 7.67 | 138,110 | |
05/05/2025 | 7.60 | 7.72 | 7.25 | 7.25 | 41,947 | |
05/02/2025 | 7.75 | 8.30 | 7.64 | 7.82 | 60,731 | |
05/01/2025 | 8.01 | 8.03 | 7.55 | 7.56 | 16,309 | |
04/30/2025 | 7.39 | 8.01 | 7.19 | 7.99 | 40,739 | |
04/29/2025 | 7.40 | 7.60 | 7.10 | 7.51 | 20,729 | |
04/28/2025 | 7.38 | 7.50 | 7.13 | 7.42 | 30,550 | |
04/25/2025 | 7.47 | 7.67 | 7.10 | 7.32 | 68,941 | |
04/24/2025 | 6.97 | 7.76 | 6.94 | 7.60 | 56,688 | |
04/23/2025 | 6.88 | 7.14 | 6.72 | 6.90 | 45,398 |
About Atara Biotherapeutics Stock history
Atara Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Atara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Atara Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Atara Biotherapeutics stock prices may prove useful in developing a viable investing in Atara Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 7.5 M | 7.9 M | |
| Net Loss | -205.5 M | -215.7 M |
Atara Biotherapeutics Stock Technical Analysis
Atara Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Atara Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Atara Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Atara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Atara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1956 | |||
| Jensen Alpha | 0.8536 | |||
| Total Risk Alpha | 0.2679 | |||
| Sortino Ratio | 0.1763 | |||
| Treynor Ratio | 2.2 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Atara Stock analysis
When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |